1
0
0
(1 - 17 von 17
)
Andreas Mühler - a….de
Andreas Mühler war ein Komponist.. Andreas Mühler.
Immunic Reports Start of Enrollment into Clinical Phase 2 Study with...
markets.businessinsider.com
DGAP-Media :33 Immunic Reports Start of Enrollment into Clinical Phase 2 Study with IMU-838 in Patients with Ulcerative Colitis F...
Novel Drug for Relapsing-Remitting MS: New Phase 2 DataMedscape
www.medscape.com
— ... profile" compared with other DHODH inhibitors, Andreas Muehler, MD, chief medical officer at Immunic, told Medscape Medical News.
Immunic Inc. (IMUX) CEO Daniel Vitt on Q Results
seekingalpha.com
— Andreas Muehler on the call. Please note, all participants will be in listen-only mode and this event is being recorded. After today's ... › article
Immunic, Inc. to Participate in Scientific and Investor Conferences...
www.prnewswire.com
Attending from the company will be Daniel Vitt, Ph.D., Chief Executive Officer and President; Andreas Muehler, M.D., Chief Medical Officer; Hella Kohlhof, Ph.D., ...
Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1...
markets.businessinsider.com
Andreas Muehler, M.D., Chief Medical Officer of Immunic, noted, "Backed by strong preclinical data and a unique profile, IMU-838 has the ...
Immunic, Inc. (IMUX) Q Earnings Call TranscriptSeeking Alpha
seekingalpha.com
— Andreas Muehler - Chief Medical Officer. Conference Call Participants. Andreas Argyrides - Wedbush. Yasmeen Rahimi - Piper Sandler.
Immunic, Inc. Announces Enrollment of First Patient in its Phase 3...
www.prnewswire.com
· ... ethics committees and regulators reflects and validates our approach," added Andreas Muehler, M.D., Chief Medical Officer of Immunic.
Immunic, Inc. to Present Selected Available and Previously...
markets.businessinsider.com
... announced that Andreas Muehler, M.D., Chief Medical Officer of Immunic, will present today selected available and previously unpublished ...
Immunic, Inc. to Participate in Investor Conferences in August
www.prnewswire.com
— August : BTIG Virtual Biotechnology Conference. Duane Nash, M.D., J.D., M.B.A, Executive Chairman of Immunic, and Andreas Muehler, M.D., ... › im...
Immunic, Inc. to Participate in Scientific and Investor ...Business Insider
markets.businessinsider.com
— Attending from the company will be Daniel Vitt, Ph.D., Chief Executive Officer and President; Andreas Muehler, M.D., Chief Medical Officer; ...
Immunic, Inc. Announces EMPhASIS Interim Analysis of 10 mg Cohort...
www.prnewswire.com
· ... in the context of the design and execution of our phase 3 program," commented Andreas Muehler, M.D., Chief Medical Officer of Immunic.
Immunic Reports New Data From Phase 2 EMPhASIS Trial of ...www.prnewswire.com › news-releases › immunic-re...
www.prnewswire.com
· Heinz Wiendl for joining the event," said Andreas Muehler, M.D., Chief Medical Officer of Immunic. "We are very excited that these three ...
Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical...
www.prnewswire.com
— ... and even increased risk of anemia, osteoporosis and certain cancers," stated Andreas Muehler, M.D., Chief Medical Officer of Immunic. › im...
Immunic to Participate in Investor and Scientific ...PR Newswire
www.prnewswire.com
— Andreas Muehler, M.D., Chief Medical Officer of Immunic, will attend this conference in New Orleans, Louisiana.
Verwandte Suchanfragen zu Andreas Mühler
Thomas Balzer Manfred Gröppel Hella Kohlhof | Daniel Vitt Nicole Lotz Rolf Andreas | Andreas Graf Thomas George Peter Rosiepen |
Person "Mühler" (1) Vorname "Andreas" (97752) Name "Mühler" (90) |
sortiert nach Relevanz / Datum